OrSense obtains FDA clearance to commercialize NBM200 System in US
Image: OrSense secures FDA market clearance for NBM200 noninvasive hemoglobin system. Photo: Courtesy of PRNewswire.
NS Medical Devices is using cookies
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X